Health
Moderna coronavirus vaccine candidate moves to phase 3 with 30,000 participants – News-Medical.Net
The world’s most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National…
The world’s most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National Institutes of Health and Moderna Inc.
The U.S. biotech firm Moderna announced that it had started the final stage of its human trials for its experimental COVID-19 vaccine in the U.S. The phase 3 human clinical trial comes after the compan…
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General18 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General23 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says
-
Noosa News18 hours agoThe Best Things to Do in Brisbane This New Year’s Eve